CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kushi, L. H.
Right arrow Articles by Folsom, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kushi, L. H.
Right arrow Articles by Folsom, A. R.

Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 1 11-19, Copyright © 1995 by American Association for Cancer Research


ARTICLES

Dietary fat and risk of breast cancer according to hormone receptor status

LH Kushi, JD Potter, RM Bostick, CR Drinkard, TA Sellers, SM Gapstur, JR Cerhan and AR Folsom
Division of Epidemiology, University of Minnesota School of Public Health, Minneapolis 55454.

The association of dietary fat with breast cancer in prospective cohort studies has generally been weak and not statistically significant. However, these studies have not considered whether the risk related to fat intake may differ according to estrogen or progesterone receptor status. Dietary habits and other breast cancer risk factors were assessed by mailed questionnaire in January 1986 in 34,388 postmenopausal Iowa women. Through 1991, 724 incident breast cancer cases were ascertained in this cohort using the Iowa cancer registry. Joint estrogen and progesterone receptor status was determined for 479 (66%) breast cancers. For tumors that were positive for both estrogen and progesterone receptors (ER+/PR+) (n = 329), age- and energy-adjusted relative risks for breast cancer adjusted from lowest to highest third of fat intake were 1.0, 1.05, and 1.22 (P trend = 0.14). Corresponding risks for ER+/PR- tumors (n = 75) were 1.0, 0.85, and 1.05 (P trend = 0.86) and for ER-/PR- tumors (n = 61) were 1.0, 1.06, and 0.73 (P trend = 0.68). Only 14 cases were classified as having ER-/PR+ tumors. Adjustment for other breast cancer risk factors did not appreciably alter these findings. There was a suggestion that dietary fat may be associated with ER+/PR+ breast cancers and not other breast cancers. These results are also consistent with an interpretation of no association between dietary fat with breast cancer, regardless of hormone receptor status. It has been suggested that etiological studies of breast cancer should investigate associations according to receptor status. This study provides evidence of a subset of breast cancers that may be related to dietary factors.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
A. C. M. Thiebaut, A. Schatzkin, R. Ballard-Barbash, and V. Kipnis
Dietary Fat and Breast Cancer: Contributions From a Survival Trial
J Natl Cancer Inst, December 20, 2006; 98(24): 1753 - 1755.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Bardia, L. C. Hartmann, C. M. Vachon, R. A. Vierkant, A. H. Wang, J. E. Olson, T. A. Sellers, and J. R. Cerhan
Recreational Physical Activity and Risk of Postmenopausal Breast Cancer Based on Hormone Receptor Status
Arch Intern Med, December 11, 2006; 166(22): 2478 - 2483.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. T. Fung, F. B. Hu, M. L. McCullough, P. K. Newby, W. C. Willett, and M. D. Holmes
Diet Quality Is Associated with the Risk of Estrogen Receptor-Negative Breast Cancer in Postmenopausal Women
J. Nutr., February 1, 2006; 136(2): 466 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. M Velie, C. Schairer, A. Flood, J.-P. He, R. Khattree, and A. Schatzkin
Empirically derived dietary patterns and risk of postmenopausal breast cancer in a large prospective cohort study
Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1308 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D. Althuis, J. H. Fergenbaum, M. Garcia-Closas, L. A. Brinton, M. P. Madigan, and M. E. Sherman
Etiology of Hormone Receptor-Defined Breast Cancer: A Systematic Review of the Literature
Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1558 - 1568.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Stripp, K. Overvad, J. Christensen, B. L. Thomsen, A. Olsen, S. Moller, and A. Tjonneland
Fish Intake Is Positively Associated with Breast Cancer Incidence Rate
J. Nutr., November 1, 2003; 133(11): 3664 - 3669.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Cho, D. Spiegelman, D. J. Hunter, W. Y. Chen, M. J. Stampfer, G. A. Colditz, and W. C. Willett
Premenopausal Fat Intake and Risk of Breast Cancer
J Natl Cancer Inst, July 16, 2003; 95(14): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Ursin, C.-C. Tseng, A. Paganini-Hill, S. Enger, P. C. Wan, S. Formenti, M. C. Pike, and R. K. Ross
Does Menopausal Hormone Replacement Therapy Interact With Known Factors to Increase Risk of Breast Cancer?
J. Clin. Oncol., February 1, 2002; 20(3): 699 - 706.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.